Clinical trial
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
NCT03650361 is registered in ClinicalTrials.gov with Aleor Dermaceuticals Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
- Lead sponsor
- Aleor Dermaceuticals Limited
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 17, 2018
- Completion date
- February 16, 2019
- Enrollment
- 755 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.